期刊文献+

磷酸二酯酶及其抑制剂的研究进展 被引量:26

Research progress of phosphodiesterases and phosphodiesterase inhibitors
下载PDF
导出
摘要 磷酸二酯酶(PDEs)是一类可水解细胞内第二信使环磷酸腺苷(cyclic adenosine monophosphate,cAMP)和环磷酸鸟苷(cyclic guanosine monophosphate,cGMP)的酶类,可调节细胞内的多种信号传递和生理活动。PDEs由11种不同的家族组成,且各家族包含不同的亚型,各个亚型在细胞内分布、表达、调节方式以及对抑制剂的敏感性均不同,参与了炎症、哮喘、抑郁、勃起功能障碍等多种病理过程的发生发展,这些特点使得PDE作为新的药物靶点得到了越来越多的关注。该文将从PDE各家族生物学特点、生理病理学意义及其抑制剂的应用作一简单综述。 Intracellular levels of ubiquitous transduction signal cyclic adenosine 3', 5'-monophosphate (cAMP) and cyclic guanosine 3', 5'-monophosphate (cGMP) are partly determined by the hydrolysis by phosphodiesterases (PDEs). So far, the su-perfamily of PDE is composed of at least 11 isoforms and each family is characterized with unique cellular distribution, expres- sion, regulation mode and inhibitor sensitivity, and PDEs are considered to be involved in a variety of pathological processes,such as inflammation, asthma, depression, and erectile dysfunc-tion, etc. Currently, these characteristics draw PDEs more and more attention as great targets for drugs. In this review, the bas-ic biochemical properties, cellular regulation, expression pat-tern, physiological functions and inhibitors of different PDE iso- forms will be briefly discussed.
作者 陈昌亮 黄爽
出处 《中国药理学通报》 CAS CSCD 北大核心 2014年第2期283-286,共4页 Chinese Pharmacological Bulletin
基金 上海高校特聘教授(东方学者)岗位计划资助(No 2010-51)
关键词 磷酸二酯酶 磷酸二酯酶抑制剂 CAMP CGMP PDE4 PDE5 PDE PDE inhibitors cAMP cGMP PDE4 PDE5
  • 相关文献

参考文献35

  • 1Rondina M T, Weyrich A S. Targeting phosphodiesterases in anti-platelet therapy[J]. Handb Exp Pharmacol, 2012, 210: 225-38.
  • 2张莉,杜冠华.磷酸二酯酶7:一个新的抗炎免疫药物靶点研究进展[J].中国药理学通报,2009,25(1):1-4. 被引量:11
  • 3Giachini F R, Lima V V, Carneiro F S, et al. Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats[J]. Hypertension,2011, 57(3): 655-63.
  • 4Noguera M A, Ivorra M D, Lugnier C, et al. Role of cyclic nucleotide phosphodiesterase isoenzymes in contractile responses of denuded rat aorta related to various Ca2+ sources[J]. Naunyn Schmiedebergs Arch Pharmacol,2001, 363 (6): 612-9.
  • 5Cygnar K D, Zhao H Q. Phosphodiesterase 1C is dispensable for rapid response termination of olfactory sensory neurons[J]. Nat Neurosci, 2009, 12(4): 454-62.
  • 6Patyar S, Prakash A, Modi M, et al. Role of vinpocetine in cerebrovascular diseases[J]. Pharmacol Rep, 2011, 63(3): 618-28.
  • 7Mijailovic M, Lukic S, Laudanovic D, et al. Effects of Nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular Coiling[J]. Adv Clin Exp Med,2013, 22(1): 101-9.
  • 8Jeon K I, Jono H, Miller C L, et al. Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells[J]. FEBS J, 2010, 277(24): 5026-39.
  • 9Morita H, Murata T, Shimizu K,et al. Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells[J]. Oncol Rep, 2013, 29(4): 1275-84.
  • 10Reneerkens O A, Rutten K, Bollen E, et al. Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801[J]. Behav Brain Res, 2013, 236(1):16-22.

二级参考文献114

  • 1王永锋,李秀珍.磷酸二酯酶-4抑制剂在支气管哮喘和慢性阻塞性肺病中的临床研究进展[J].临床肺科杂志,2006,11(1):49-52. 被引量:11
  • 2李小明,胡爱虹.磷酸二酯酶抑制剂的药理及临床应用进展[J].安徽医药,2006,10(6):464-466. 被引量:8
  • 3孙超渊,张莉,程克棣,杜冠华,朱平.磷酸二酯酶4研究进展[J].中国药理学通报,2006,22(10):1161-1167. 被引量:19
  • 4谢诒诚,郑晓亮,钱伯初.磷酸二酯酶-4抑制剂治疗哮喘和慢性阻塞性肺疾病的研究进展[J].世界临床药物,2007,28(1):19-22. 被引量:4
  • 5Soderling S H, Bayuga S J, Beavo J A. Identification and characterization of a novel family of cyclic nucleotidc phosphodiesterases [J]. J Biol Chem,1998, 273(25) : 15553 -8.
  • 6Giembycz M A. Development status of second-generation PDE4 inhibitors for asthma and COPD: the story so far[ J] ? Monaldi Arch Chest Dis, 2002, 57( 1 ) :48 -64.
  • 7Losco P E, Evans E W, Barat S A, et al. The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys[ J]. Toxicol Pathol, 2004, 32 (3) :295 - 308.
  • 8Michaeli T, Bloom T J, Martins T, et al. Isolation and character- ization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae[ J]. J Biol Chem, 1993, 268 ( 17 ) : 12925 - 32.
  • 9Sasaki T, Kotera J, Yuasa K, Omori K. Identification of human PDE7B, a cAMP-specific phosphodiesterase[ J]. Biochem Biophys Res Continua, 2000, 271(3 ) : 575 - 83.
  • 10Glavas N A, Ostenson C, Schaefer J B, et al. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3 [J].Proc Natl Acad Sci USA, 2001 , 98 ( 11 ) : 6319 - 24.

共引文献46

同被引文献349

引证文献26

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部